JEFFREY M CHUNG

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology WEST HOLLYWOOD, CA NPI 1437106366

General Payments — all program years on this page

$17,286.49

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 46
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $9,982.43 across 11 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $8,943.751
Travel and Lodging $754.293
Food and Beverage $284.397

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $9,964.0410
NEUROPACE, INC. $18.391

By program year

Program yearAmountRecords
2018 $3,730.187
2019 $3,335.7625
2020 $238.123
2024 $9,982.4311

Records — PY2024 (11)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1137513465 Takeda Pharmaceuticals U.S.A., Inc. $122.17 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137513469 Takeda Pharmaceuticals U.S.A., Inc. $22.80 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137513473 Takeda Pharmaceuticals U.S.A., Inc. $196.81 03/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137513477 Takeda Pharmaceuticals U.S.A., Inc. $38.01 03/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137513481 Takeda Pharmaceuticals U.S.A., Inc. $17.33 03/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137513485 Takeda Pharmaceuticals U.S.A., Inc. $47.44 03/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137513488 Takeda Pharmaceuticals U.S.A., Inc. $18.25 03/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137513492 Takeda Pharmaceuticals U.S.A., Inc. $545.68 05/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137513496 Takeda Pharmaceuticals U.S.A., Inc. $8,943.75 05/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137513500 Takeda Pharmaceuticals U.S.A., Inc. $11.80 05/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1153275456 NEUROPACE, INC. $18.39 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.